2 recruiting, 1 not yet recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Not yet recruiting 1 |
Follow UTUC: new trials by email Literature Review of UTUC trials Research Report on UTUC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC Trastuzumab Rezetecan, Gemcitabine, Radical nephroureterectomy - UTUC | Phase 2 | Recruiting | Zhiquan Hu | 54 | 2026-08-15 | 2026-08-03 |
| Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma Gemcitabine, Cisplatin - UTUC, NAC | Phase 2 | Not yet recruiting | Changhai Hospital | 45 | 2025-05-15 | 2025-04-15 |
| A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma RC48-ADC and JS001 - Carcinoma, Upper Tract Urothelial Carcinoma | Phase 2 | Recruiting | Jinling Hospital, China | 30 | 2022-11-23 | 2025-01-22 |
Carcinoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Gemcitabine (2) · Cisplatin (1)
Changhai Hospital (1) · Jinling Hospital, China (1) · Zhiquan Hu (1)
China (3)